ReCell Placement and Medical Procedure Overview

Target news flow - 2011-2012 ■ Results from United States FDA burns and scar trials and subsequent clearance of ReCell® for sales within the United States market Trial Dec-11 Burns Trial Full recruitment Jun-12 Dec-12 Jun-13 Results Scar Trial* IDE approval and commence recruitment Full recruitment Results & submit application to FDA Results & FDA application Approve and on market in US On market *Assumes IDE as proposed is approved by FDA ■ Additional Patents Issued ■ Market Development: - Appointment of Distributors - Initiation of Joint Ventures - China - pricing registration through Chinese Ministry of Health; commencement of sales ■ Product expansion Expansion of ReCell® product line 32 medical avita

View entire presentation